Hemera Biosciences: Clinical Trials

1 trial sponsored by Hemera Biosciences, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Withdrawn 1

Follow Hemera Biosciences: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)
Intravitreal AAVCAGsCD59, Intravitreal Sham Injection - Dry Age-related Macular Degeneration, Geographic Atrophy
Phase 2WithdrawnHemera Biosciences2021-07-312021-05-10

Conditions studied

Geographic Atrophy (1)

Interventions

salicylhydroxamic acid (1)